Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1357
| Despition | P2Y12 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1661 | Human HEXA Protein, Sf9 (AC1661) | 2 µg | inquiry |
| ACPP-1757 | Human Artemin Protein (AC1757) | 5 µg | inquiry |
| ACPP-1728 | Human Human C Peptide (Active) Protein (AC1728) | 100 µg | inquiry |
| ACPP-1571 | Human OTOR Protein, His (AC1571) | 5 µg | inquiry |
| ACPP-1581 | Rat FGF 9 Protein (AC1581) | 2 µg | inquiry |
| ACPP-1137 | Recombinant HuD Antigen (AC1137) | 100 µg | inquiry |
| ACPP-1399 | Human LGALS7 Protein (AC1399) | 2 µg | inquiry |
| ACPP-1272 | Bestrophin Blocking Peptide (AC1272) | 250 µg | inquiry |
| ACPP-1670 | Mouse BDNF Protein (AC1670) | 2 µg | inquiry |
| ACPP-1738 | Human PNOC Protein (AC1738) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.